Pri-med Podcasts

Credits: 0.50 AMA PRA Category 1 Credit™    CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/pain-management-beyond-pills-surgeries  Overview: Join Dr. Charles Vega as he interviews Dr. Kunal Sood, a leading expert in interventional pain medicine who specializes in diagnosing and treating chronic neck, back, and joint pain. Learn from his wealth of experience as he demystifies misconceptions about pain management, shares insights into the world of pain management, and discusses the role pain specialists in care of patients with chronic pain. 

Credits: 0.25 AMA PRA Category 1 Credit™    CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/exploring-strategies-diabetes-obesity-management  Overview: Join primary care physician Charles Vega, MD and renowned endocrinologist Mike Natter, MD, as they explore the profound connection between art, personal health journeys, and medical practice. In this captivating podcast, Dr. Mike Natter will share how his experience as a patient with type 1 diabetes and passion for art have transformed his approach to patient care. Learn about his insights into endocrinology, addressing common misconceptions, and his strategies for caring for patients with diabetes and obesity.

Credits: 0.50 AMA PRA Category 1 Credit™    CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/managing-drug-drug-interactions-non-hospitalized-patients   Overview: This in-depth discussion provides guidance on the options available to clinicians for managing potential drug-drug interactions in non-hospitalized patients with COVID-19. Hear practical strategies for increased monitoring, dosage adjustments, and exploring alternative medications to enable the safe use of anti-COVID-19 therapies. Faculty also discuss when consultation with a pharmacist and/or patient’s specialist is advised. 

Credits: 0.25 AMA PRA Category 1 Credit™    CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/treatment-non-hospitilized-patients-covid-19  Overview: Join expert faculty as they discuss risk stratification for non-hospitalized patients with mild or moderate COVID-19 to determine who would benefit most from antiviral therapy aimed at reducing the risk of progression to severe disease. Explore national guideline recommendations on COVID-19 treatment in non-hospitalized patients, including factors to consider when selecting therapy for individual patients. 

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354 Overview: There is an overlap of acute sinusitis symptoms and viral upper respiratory tract infection, such that many children are treated unnecessarily with antibiotics. In this episode, we review 2 recent studies that inform recommendations on whether or not to treat childhood sinusitis with amoxicillin/clavulanate. Gain practical strategies and the confidence to appropriately address sinusitis in the children you treat. Episode resource links: JAMA. 2023;330(4):349-358. doi:10.1001/jama.2023.10854 JAMA. 2023;330(11):1064-1073. doi:10.1001/jama.2023.15503 Journal of Pediatrics, The, 2019-04-01, Volume 207, Pages 103-108.e1 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.50 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-ask-the-expert  Overview: In this podcast, Dr Katherine Galluzzi will answer frequently asked questions regarding opioid therapy, such as: Best practices for tapering opioids; Assessing for opioid use disorder and distinguishing between tolerance, dependence, misuse, and abuse; Strategies for counseling patients with pain; Nonpharmacologic and non-opioid treatment options; and What to do when a patient approaches the “ceiling” of safe opioid dosing. This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf  for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353 Overview: Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now 2 ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice. Episode resource links: Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1115–1122. Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352 Overview: Keep your practice at the forefront of outpatient COVID-19 management with this informative episode. Listen in as expert faculty discuss the latest recommendations and review ineffective treatments, helping you provide the best care during this new phase of the endemic. Episode resource links: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&utm_medium=home&utm_campaign=highlights Abdool Karim, S. S., & Devnarain, N. (2022). Time to stop using ineffective COVID-19 drugs. New England Journal of Medicine, 387(7), 654-655. Hayden, M. K., Hanson, K. E., Englund, J. A., Lee, F., Lee, M. J., Loeb, M., ... & Mustafa, R. A. (2023). The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clinical Infectio

Credits: 0.50 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-outcomes-special-populations  Overview: Tapering opioids is frequently necessary in clinical practice, either to reduce harm or because of lack of significant benefit. The most important aspect of opioid tapering is discussing the reasons for it with the patient. Opioid tapering should be a measure of safety—and in no way punitive. Complete this activity to learn appropriate and inappropriate reasons for tapering opioid therapy and strategies to counsel patients and manage withdrawal and psychological issues. This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf  for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Fo

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351 Overview: Live at Pri-Med East! In this episode, we will examine the association of developmental delays with amount of screen time in children. Episode resource links: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593 https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/ https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

Credits: 0.50 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-breaking-opioid-cycle  Overview: Tapering opioids is frequently necessary in clinical practice, either to reduce harm or because of lack of significant benefit. The most important aspect of opioid tapering is discussing the reasons for it with the patient. Opioid tapering should be a measure of safety—and in no way punitive. Complete this activity to learn appropriate and inappropriate reasons for tapering opioid therapy and strategies to counsel patients and manage withdrawal and psychological issues. This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and D

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350 Overview: Nuts have a reputation for providing a variety of health benefits, but how far do their nutritional superpowers reach? In this episode, we take a look at the findings of a study showing the association between nut consumption and cognitive performance. Listen in as expert faculty discuss the implications for managing patients at risk for cognitive decline. Episode resource links: The American Journal of Clinical Nutrition https://doi.org/10.1016/j.ajcnut.2023.05.032 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-349 Overview: Recent observational data has shown the potential for bariatric surgery to lower breast cancer risk in women with obesity. Tune in as faculty discuss what the evidence says about this connection and when to consider exploring the option for your patients’ weight-loss management. Episode resource links: AMA Surg. 2023 Jun 1;158(6):634-641. doi: 10.1001/jamasurg.2023.0530. J Natl Cancer Inst. 2003;95(16):1218. J Natl Cancer Inst. 2015;107(2) Epub 2015 Mar 10.  Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-348 Overview: Discover how wearable fitness devices are transforming early detection of atrial fibrillation with their potential to reduce stroke risk. In this episode, we share insights on leveraging smartwatches to improve health outcomes and when to encourage their use in patient care. Episode resource links: Bedi, A., Al Masri, M. K., Al Hennawi, H., Qadir, S., & Ottman, P. (2023). The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch. Cureus, 15(3). Long, K. Y., Shanmugam, K., & Rana, M. E. (2023, January). An Evaluation of Smartwatch Contribution in Improving Human Health. In 2023 17th International Conference on Ubiquitous Information Management and Communication (IMCOM) (pp. 1-4). IEEE. Mattison, G., Canfell, O. J., Forrester, D., Dobbins, C., Smith, D., Reid, D., & Sullivan, C. (20

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-347 Overview: In this episode, we’re diving into recent research that uncovers a compelling link between obstructive sleep apnea and cognitive decline in older adults. Join expert faculty as they dissect the findings and provide invaluable insights to comprehensively address this connection in your practice. Episode resource links: Discuss recent evidence that links obstructive sleep apnea (OSA) to cognitive decline risk in older people Describe ways to incorporate this new evidence to identify OSA and reduce the risk of cognitive decline  Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346 Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients.  Episode resource links: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-345 Overview: In this episode, we discuss the findings of a recent Lancet publication on a novel neurokinin 3 (NK3) receptor antagonist for treating hot flashes. Tune in as we talk about how this nonhormonal treatment addresses menopausal hot flashes, the prescribing precautions issued by the FDA, and the implications for patients seeking your help with alleviating symptoms. Episode resource links: Lancet 2023; 401: 1091–102. doi.org/10.1016/ S0140-6736(23)00085-5 Am Fam Physician. 2023;108(1):28-39 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/nhlbi-breathe-better-pulmonary-fibrosis   Overview: “Pulmonary Fibrosis: What Primary Care Providers Need to Know” is a CME podcast episode produced by Pri-Med in partnership with Learn More Breathe Better®, a program of the National Heart, Lung, and Blood Institute of the National Institutes of Health. In this episode, we are joined by Dr. Matt Craig, Chief of the Lung Biology and Disease Branch with NHLBI’s Division of Lung Diseases, and Dr. Fernando J. Martinez, Chief of the Pulmonary and Critical Care Medicine Division at Weill Cornell Medicine. Today we’ll be discussing pulmonary fibrosis and the role of primary care providers, including signs to look out for, diagnosis, and treatment options.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/nhlbi-sarcoidosis-in-lungs   Overview: “Sarcoidosis in the Lungs: What Primary Care Providers Should Know” is a CME podcast episode produced by Pri-Med in partnership with Learn More Breathe Better®, a program of the National Heart, Lung, and Blood Institute of the National Institutes of Health. In this episode, we are joined by Dr. George Mensah, Director of the NHLBI Center for Translation Research and Implementation Science, and Dr. Mridu Gulati, Associate Professor of Medicine at Yale School of Medicine. We’ll be discussing what general practitioners should know about sarcoidosis, including the risk factors, symptoms, challenges in diagnosis, and how sarcoidosis is treated.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/nhlbi-cystic-fibrosis  Overview: “Cystic Fibrosis: The Primary care Provider’s Role in Case Finding and Referral” is a CME podcast episode produced by Pri-Med in partnership with Learn More Breathe Better®, a program of the National Heart, Lung, and Blood Institute of the National Institutes of Health. In this episode, we are joined by Dr. Marrah Lachowicz-Scroggins, Program Director with NHLBI’s Division of Lung Diseases, and Dr. Deepika Polineni, director of the Cystic Fibrosis Center, Washington University School of Medicine in St. Louis. We’ll be discussing what general practitioners should know about cystic fibrosis, including the factors that contribute to delayed or missed diagnosis, and the similarities and differences with primary ciliary dyskinesia, or PCD.